BF-ESSE: FDA-Registered European Supplement Manufacturer for U.S. Projects
For European supplement manufacturers, entering the U.S. market is not simply a matter of producing the same product and changing the language on the label. The United States has its own regulatory framework for dietary supplements, its own manufacturing requirements and its own import procedures.
For BF-ESSE, one of the first formal steps in developing a manufacturing route for U.S. customers has now been completed: the company’s manufacturing facility in Riga, Latvia is registered with the U.S. Food and Drug Administration as a foreign food facility.
For supplement brands looking for a European manufacturing partner, this is an important starting point. But understanding what FDA registration means — and what it does not mean — is just as important as the registration itself.
For BF-ESSE, one of the first formal steps in developing a manufacturing route for U.S. customers has now been completed: the company’s manufacturing facility in Riga, Latvia is registered with the U.S. Food and Drug Administration as a foreign food facility.
For supplement brands looking for a European manufacturing partner, this is an important starting point. But understanding what FDA registration means — and what it does not mean — is just as important as the registration itself.
Why FDA Food Facility Registration matters
Foreign facilities that manufacture, process, pack or hold food intended for consumption in the United States may be required to register with FDA.
Dietary supplements fall within the U.S. food regulatory framework, which means facility registration becomes one of the first questions when a foreign contract manufacturer plans to supply the American market.
For a U.S. brand evaluating a manufacturer in Europe, registration establishes that the manufacturing facility is present in FDA's food facility registration system for the activities and product categories declared in its record.
It also means that the foreign facility has designated a U.S. agent for communications with FDA.
This removes one basic uncertainty at the beginning of a project. Instead of asking whether the European manufacturing site is registered at all, the conversation can move toward the product itself.
And that is where most of the real work begins.
FDA registered does not mean FDA approved
The phrase “FDA registered” is frequently misunderstood in the supplement industry.
Food Facility Registration is not an FDA approval of the manufacturer. It is also not certification or endorsement by FDA.
Food Facility Registration is not an FDA approval of the manufacturer. It is also not certification or endorsement by FDA.
Registration does not mean that FDA has approved every dietary supplement produced at the site, approved its formulas or reviewed its labels.
For the same reason, a registration number should not be treated as evidence that every manufacturing operation automatically complies with the dietary supplement current good manufacturing practice requirements in 21 CFR Part 111.
Those are separate requirements.
For the same reason, a registration number should not be treated as evidence that every manufacturing operation automatically complies with the dietary supplement current good manufacturing practice requirements in 21 CFR Part 111.
Those are separate requirements.
For BF-ESSE, the correct description is therefore straightforward:
the Riga manufacturing facility is registered with FDA as a foreign food facility.
The regulatory assessment of an actual U.S. product still has to be performed project by project.
the Riga manufacturing facility is registered with FDA as a foreign food facility.
The regulatory assessment of an actual U.S. product still has to be performed project by project.
A European formula cannot simply be copied into the U.S. market
This distinction becomes particularly important when a product was originally developed for sale in the European Union.
Europe and the United States both have established supplement markets, but their regulatory systems are not interchangeable.
Europe and the United States both have established supplement markets, but their regulatory systems are not interchangeable.
- A product sold in Europe as a food supplement may require a separate review before being manufactured as a dietary supplement for the United States.
- A capsule, powder or stick pack may be straightforward from a manufacturing perspective while still raising regulatory questions about ingredients, specifications, claims or labeling.
-
That is why BF-ESSE intends to approach U.S. manufacturing projects from the target market backward: first establish what the finished U.S. product is supposed to be, then connect the formulation, manufacturing process, testing, packaging and documentation to that product.
Manufacturing dietary supplements for the United States
BF-ESSE operates as a European contract manufacturer and CDMO for food supplements.
At its Riga manufacturing facility, the company works with several dosage and packaging formats, including capsule filling, powder blending, stick packs and sachets, blister packaging and bottling.
At its Riga manufacturing facility, the company works with several dosage and packaging formats, including capsule filling, powder blending, stick packs and sachets, blister packaging and bottling.
These capabilities create several potential routes for U.S.-market projects, particularly in herbal and botanical supplements, which correspond most directly with the categories currently identified in the company's FDA facility record.
Before production, the project still has to connect the raw-material specifications, formulation, manufacturing controls, testing strategy, packaging and finished-product requirements.
Before production, the project still has to connect the raw-material specifications, formulation, manufacturing controls, testing strategy, packaging and finished-product requirements.
For dietary supplements manufactured for the United States, the applicable current good manufacturing practice framework is established under 21 CFR Part 111.
That makes U.S. production more than an export exercise. It becomes a separate manufacturing project.
That makes U.S. production more than an export exercise. It becomes a separate manufacturing project.
A hand holds a white jar with an orange "Supplement Facts" label
Labeling is another area where European products cannot simply be transferred unchanged.
U.S. dietary supplements use a Supplement Facts panel and are subject to specific requirements covering product identity, ingredient declarations, serving information, net contents and the name and place of business of the manufacturer, packer or distributor.
Claims also have to be considered separately.
Wording that has been used successfully on an EU food supplement should not automatically be assumed to work in the United States.
For a contract manufacturer, this matters even when the customer remains responsible for final market-facing artwork. The product manufactured in the facility still needs to correspond with the approved formula, specifications and packaging information used during production.
Resolving these questions before printed packaging is ordered can prevent considerably more expensive corrections later.
Claims also have to be considered separately.
Wording that has been used successfully on an EU food supplement should not automatically be assumed to work in the United States.
For a contract manufacturer, this matters even when the customer remains responsible for final market-facing artwork. The product manufactured in the facility still needs to correspond with the approved formula, specifications and packaging information used during production.
Resolving these questions before printed packaging is ordered can prevent considerably more expensive corrections later.
What FDA registration changes for BF-ESSE
For BF-ESSE, FDA Food Facility Registration is not being treated as a marketing badge or as a statement that every product manufactured in Riga is automatically ready for the United States.
Its practical value is different.
Its practical value is different.
-
It creates the facility-level foundation from which BF-ESSE can begin evaluating relevant U.S. dietary supplement projects with customers.
A company approaching BF-ESSE with a food supplement concept can now move directly into the questions that matter for the actual product: formulation, ingredient specifications, dosage form, manufacturing feasibility, testing, packaging, U.S. labeling requirements and import responsibilities. -
The earlier these questions are addressed, the easier it becomes to determine whether a project has a realistic manufacturing route.
For brands considering supplement manufacturing in Europe for the U.S. market, that is ultimately much more useful than the words “FDA registered” alone.
FDA registration gets the facility into the system.
Information notice
This article provides general information and is not legal or regulatory advice. Requirements depend on the product, ingredients, claims, parties and supply chain.